CD274 and neoplasm: As a result, Laenkholm and his colleagues advised caution when using TILs as a prognostic factor, as well as combining it with other well-established prognostic factors like tumor size and lymph node status, as well as performing the assessment in conjunction with PD-L1 IHC [38].